Fresenius Medical Care (NYSE: FMS), the world’s largest provider of dialysis products and services, announced that Franklin W. Maddux, M.D., FACP, has been appointed Chief Medical Officer (CMO) for Fresenius Medical Care North America (FMCNA), effective December 12, 2011. In this role he will also be responsible for Clinical and Scientific Affairs.
Dr. Maddux will report to Rice Powell, Chief Executive Officer of Fresenius Medical Care North America and Deputy Chairman of the Management Board, who commented: “We are very excited to have Frank expand his role with Fresenius Medical Care. Frank has been working for us since 2009 and has an impressive experience in the health-care industry. He is an outstanding choice as his career and research interests have focused on the quality of care for chronic kidney disease patients.”
In his new role, Dr. Maddux will oversee the delivery of quality care to more than 140,000 dialysis patients across the United States, and will direct a number of clinical studies and initiatives programs designed to improve dialysis care in the future.
Dr. Maddux joined FMCNA in 2009 after the company acquired Health IT Services Group, a leading-edge Electronic Health Record software company that he founded in 2007. He has more than 25 years of experience in the health-care industry, including the practice of nephrology. Dr. Maddux also serves as Clinical Associate Professor of Medicine at the University of North Carolina School Of Medicine. He has served on numerous boards and committees involved in developing technology initiatives in both the medical and regional economic development arenas. Dr. Maddux received his bachelor’s degree in mathematics from Vanderbilt University and an MD degree from the University of North Carolina at Chapel Hill.Dr. Maddux replaces Dr. Raymond Hakim, a true leader in the dialysis industry who helped FMCNA place a sharp focus on the highest quality patient care.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV